share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  05/28 22:33

Moomoo AI 已提取核心信息

Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 05/28/2024, as per the latest filing. These shares, originally acquired on 09/01/2016 as founders shares, are part of Borgeson's compensation from the issuer. The planned sale is valued at approximately $104,942.40 based on current market values. This transaction follows a series of sales over the past three months, where Borgeson sold a total of 94,503 shares, amounting to gross proceeds of $940,795.11. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 08/18/2023.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 05/28/2024, as per the latest filing. These shares, originally acquired on 09/01/2016 as founders shares, are part of Borgeson's compensation from the issuer. The planned sale is valued at approximately $104,942.40 based on current market values. This transaction follows a series of sales over the past three months, where Borgeson sold a total of 94,503 shares, amounting to gross proceeds of $940,795.11. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 08/18/2023.
根据最新文件,Recursion Pharmicals, Inc.董事布莱克·博格森定于2024年5月28日出售该公司的11,447股A类股票。这些股票最初于2016年1月9日作为创始人股票收购,是博格森从发行人那里获得的薪酬的一部分。根据目前的市场价值,计划出售的价值约为104,942.40美元。该交易是在过去三个月进行的一系列销售之后进行的,博格森共出售了94,503股股票,总收益为940,795.11美元。即将进行的出售通知与计划出售的同一天提交,该交易的指示于2023年8月18日发出。
根据最新文件,Recursion Pharmicals, Inc.董事布莱克·博格森定于2024年5月28日出售该公司的11,447股A类股票。这些股票最初于2016年1月9日作为创始人股票收购,是博格森从发行人那里获得的薪酬的一部分。根据目前的市场价值,计划出售的价值约为104,942.40美元。该交易是在过去三个月进行的一系列销售之后进行的,博格森共出售了94,503股股票,总收益为940,795.11美元。即将进行的出售通知与计划出售的同一天提交,该交易的指示于2023年8月18日发出。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息